CME Group CME
$305.89 −$1.35 (-0.44%)
Market closed · Nov 6, 9:50 pm ET · Last extended-hours $305.89 0.00%
Open$303.68
Prev close$307.24
Day range$301.40 – $308.76
Volume1.45M
Market cap$109.49B
P/E (TTM)25.1
Dividend yield3.69%
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Institutional ownership91.8%-0.19 pts vs. prior quarter
Institutions holding2,057+36 vs. prior quarter
Insider trades (recent)32 buys / 17 sellsNet buying
Short interest1.39% of floatDays to cover 2.6 · as of 15 Oct 2026
Short-sale volume share10.7%5-day average of daily volume
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$201.46M (5 inflow days, 15 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 26.0% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 1.73% to 1.39% of float over the last 6 biweekly reports (31 Jul 2026 to 15 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Hartford Funds Management Company, LLC | Mutual Fund | 2026/Q3 | +898,210 | 0.3% |
| Millennium Management LLC | Hedge Fund | 2026/Q3 | +1,717,620 | 0.5% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +1,478,577 | 0.5% |
| Marshall Wace LLP | Hedge Fund | 2026/Q3 | +1,437,086 | 0.6% |
| Qube Research & Technologies Ltd | Mutual Fund | 2026/Q3 | +1,428,529 | 0.5% |
| Two Sigma Investments, LP | Hedge Fund | 2026/Q3 | +1,268,663 | 0.7% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q3 | +1,185,134 | 0.4% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +1,131,471 | 0.4% |
| Morgan Stanley | Public Company | 2026/Q3 | +1,049,243 | 1.3% |
| Capital Wealth Planning, LLC | Mutual Fund | 2026/Q3 | +934,355 | 0.9% |
| Sanders Capital, LLC | Mutual Fund | 2026/Q3 | +906,550 | 1.4% |
| Invesco Ltd. | Mutual Fund | 2026/Q3 | +761,588 | 0.4% |
| Arrowstreet Capital, Limited Partnership | Mutual Fund | 2026/Q3 | +675,123 | 0.9% |
| Point72 Asset Management, L.P. | Hedge Fund | 2026/Q3 | +653,666 | 0.2% |
| Renaissance Technologies Corp. | Hedge Fund | 2026/Q3 | +645,249 | 0.2% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 26 Oct 2026 | Sunil Cutinho | Chief Information Officer | Open Market Disposition | -5,000 | $298.70 | 20,037 |
| 21 Oct 2026 | Martin Gepsman | Independent Director | Open Market Disposition | -400 | $302.50 | 25,244 |
| 24 Sep 2026 | William Shepard | Independent Director | Open Market Acquisition | +292 | $268.76 | 264,356 |
| 15 Sep 2026 | Kendal Vroman | Chief Transformation Officer | Sale to Issuer | -1,211 | $275.09 | 20,232 |
| 15 Sep 2026 | Derek Sammann | Senior MD & Global Head of Commodities Markets | Sale to Issuer | -1,413 | $275.09 | 32,813 |
| 15 Sep 2026 | Sunil Cutinho | Chief Information Officer | Sale to Issuer | -1,413 | $275.09 | 25,037 |
| 15 Sep 2026 | Julie Winkler | Senior MD & Chief Commercial Officer | Sale to Issuer | -1,413 | $275.09 | 31,561 |
| 15 Sep 2026 | Jack Tobin | MD & Chief Accounting Officer | Sale to Issuer | -347 | $275.09 | 25,762 |
| 15 Sep 2026 | Tim McCourt | Senior MD & Global Head of Equities, FX and Alternative Products | Sale to Issuer | -1,334 | $275.09 | 13,366 |
| 15 Sep 2026 | John Marchese | General Counsel | Sale to Issuer | -241 | $275.09 | 3,598 |
| 15 Sep 2026 | Michael Dennis | Senior Managing Director & Global Head of Fixed Income | Sale to Issuer | -548 | $275.09 | 10,723 |
| 15 Sep 2026 | Suzanne Sprague | Senior MD, Group COO & Global Head of Clearing | Sale to Issuer | -1,152 | $275.09 | 15,548 |
| 15 Sep 2026 | Lynne Fitzpatrick | Senior MD, President & CFO | Sale to Issuer | -1,340 | $275.09 | 26,661 |
| 14 Sep 2026 | Terrence Duffy | Chairperson & CEO | Other Acquisition | +21,812 | $275.09 | 62,442 |
| 14 Sep 2026 | Kendal Vroman | Chief Transformation Officer | Other Acquisition | +2,592 | $275.09 | 20,232 |
| 14 Sep 2026 | Sunil Cutinho | Chief Information Officer | Other Acquisition | +2,864 | $275.09 | 25,037 |
| 14 Sep 2026 | Julie Winkler | Senior MD & Chief Commercial Officer | Other Acquisition | +2,864 | $275.09 | 31,561 |
| 14 Sep 2026 | Jack Tobin | MD & Chief Accounting Officer | Other Acquisition | +700 | $275.09 | 25,762 |
| 14 Sep 2026 | Tim McCourt | Senior MD & Global Head of Equities, FX and Alternative Products | Other Acquisition | +2,592 | $275.09 | 13,366 |
| 14 Sep 2026 | John Marchese | General Counsel | Other Acquisition | +784 | $275.09 | 3,598 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 4,987,983 | 1.4% | 2.6 |
| 30 Sep 2026 | 5,526,063 | 1.5% | 3.2 |
| 15 Sep 2026 | 5,801,564 | 1.6% | 3.3 |
| 31 Aug 2026 | 5,629,176 | 1.6% | 2.8 |
| 14 Aug 2026 | 5,199,595 | 1.4% | 3.1 |
| 31 Jul 2026 | 6,213,476 | 1.7% | 2.3 |
No comments yet — be the first to weigh in on CME.
Sign in to join the discussion.